These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7718641)
1. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study. Rovira A; Urbano-Ispizua A; Cervantes F; Rozman M; Vives-Corrons JL; Montserrat E; Rozman C Ann Hematol; 1995 Mar; 70(3):129-33. PubMed ID: 7718641 [TBL] [Abstract][Full Text] [Related]
2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304 [TBL] [Abstract][Full Text] [Related]
3. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Mashal R; Shtalrid M; Talpaz M; Kantarjian H; Smith L; Beran M; Cork A; Trujillo J; Gutterman J; Deisseroth A Blood; 1990 Jan; 75(1):180-9. PubMed ID: 1967214 [TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia. Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876 [TBL] [Abstract][Full Text] [Related]
5. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis. Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302 [TBL] [Abstract][Full Text] [Related]
6. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694 [TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia]. Okabe M Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066 [TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Neubauer A; He M; Schmidt CA; Huhn D; Liu ET Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238 [TBL] [Abstract][Full Text] [Related]
10. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180 [TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro. Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932 [TBL] [Abstract][Full Text] [Related]
13. Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis. Chen JC; Liu SM; Fei HB; Gong WL J Tongji Med Univ; 1994; 14(4):204-8. PubMed ID: 7760428 [TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia. Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851 [TBL] [Abstract][Full Text] [Related]
16. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A Br J Haematol; 1995 Nov; 91(3):625-9. PubMed ID: 8555065 [TBL] [Abstract][Full Text] [Related]
17. Myelomonocytic crisis with t(5;17) and a p53 mutation in a patient with chronic myelogenous leukemia. Nakagawa H; Fujii H; Nakai H; Inazawa J; Misawa S Am J Hematol; 1994 Apr; 45(4):335-40. PubMed ID: 8178805 [TBL] [Abstract][Full Text] [Related]
18. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis. Guinn BA; Smith M; Padua RA; Burnett A; Mills K Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697 [TBL] [Abstract][Full Text] [Related]
19. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536 [TBL] [Abstract][Full Text] [Related]